CMS Open Payments · Program Year 2024
Sirtex Medical Inc
Sirtex Medical Inc reported $4,231,836.24 across General Payments, Research, and Ownership to 5,226 physicians and teaching hospitals across 5,392 transactions.
- $4.2M Top quartile payer
- All-tracks total
- 5,392 Top quartile volume
- Transactions
- 5,226 Top quartile reach
- Recipients
- +$681.7K
- General Payments vs PY2023
Sirtex Medical Inc reported $4,231,836.24 across all CMS Open Payments tracks (General + Research + Ownership) to 5,226 physicians and teaching hospitals in Program Year 2024 - ranking #297 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,508,983.06, averaging $809.77 per recipient.
How Sirtex Medical Inc's $4.2M all-tracks total breaks down
Sirtex Medical Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
D
50/100
Total payments
F
49/100
Transaction volume
F
49/100
Physician reach
D
50/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer sirtex-medical-inc Sirtex Medical Inc
$4.2M · #297/1,925 · 0.0% industry · PY2024
- TOT $4.2M
- RANK #297
- SHARE 0.0%
- TXN 5,392
- RCP 5,226
- CAT 4
- GEN $2.5M
- ΔGEN +$681.7K
- TOP1 11.0%
- PY 2024
Volume peers
Nearest volume peer: Sonex Health, Inc. ($4.2M)
Sirtex Medical Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Sirtex Medical Inc's CMS-reported General Payments increased by $681.7K (+37.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: SIRTEX MEDICAL INCPY2023: SIRTEX MEDICAL INCPY2024: Sirtex Medical Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,827,251.11
- PY2024
- $2,508,983.06
What the Data Shows for Sirtex Medical Inc
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Sirtex Medical Inc, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Services Other Than Consulting" at $1.9M, accounting for 76.1% of this company's General Payments and 577 transactions.
General Payment Breakdown by Type
"Compensation for Services Other Than Consulting" leads Sirtex Medical Inc's 4-category general-payment breakdown at $1.9M, 76.1% of the reported total.
Sirtex Medical Inc reports 4 general-payment categories - the top three are Compensation for Services Other Than Consulting (76.1%), Consulting Fee (8.2%), and Travel and Lodging (7.9%). The remaining 1 category make up 7.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Sirtex Medical Inc divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $1.9M | 577 | 76.1% |
| Consulting Fee | $205.2K | 70 | 8.2% |
| Travel and Lodging | $197.0K | 1,076 | 7.9% |
| Food and Beverage | $196.8K | 3,503 | 7.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $956,127.35 (38.1%) of $2,508,983.06 in this company's General Payments records across 1,667 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Sirtex Medical Inc
The five named recipients with the highest reported General Payments from this company
- 1
Nima Kokabi
$275,346.01 across 147 reported transactions
- 2
Ripal Gandhi
$271,098.89 across 383 reported transactions
- 3
Edward Lee
$171,617.86 across 107 reported transactions
- 4
Suvranu Ganguli
$132,923.43 across 152 reported transactions
- 5
Navid Eghbalieh
$105,141.16 across 62 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Sirtex Medical Inc ranks #297 of 1,925 by total payments (top 15% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,349 of 1,838 by HHI (bottom 27% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Uoc USA Inc : $460.8K total payments, HHI 437
- ZOLL Respicardia, Inc. : $325.9K total payments, HHI 435
- Vasorum USA Inc. : $12.3K total payments, HHI 435
- Hikma Pharmaceuticals USA : $501.2K total payments, HHI 435
- Butterfly Network, Inc. : $100.3K total payments, HHI 434
- Acera Surgical, Inc. : $623.5K total payments, HHI 432
- Sirtex Medical Inc (this company) : $2.5M total payments, HHI 432
- Cycle Pharmaceuticals Inc : $34.4K total payments, HHI 430
- Eli Lilly and Company : $8.0M total payments, HHI 429
- ASD Specialty Healthcare, LLC : $5.3K total payments, HHI 428
- Extremity Medical : $657.9K total payments, HHI 428
- 3-D Matrix, Inc. : $51.0K total payments, HHI 427
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Sirtex Medical Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Sirtex Medical Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Sirtex Medical Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Ipsen Bioscience Inc.
Corcept Therapeutics
Johnson & Johnson Surgical Vision, Inc.
Kerecis Limited
Responsive Arthroscopy Inc
Put this to use
Sirtex Medical Inc ranks #297 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See where Sirtex Medical Inc sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Sirtex Medical Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.